의료진 소개
예약 안내
장정윤
[
방사선종양학과
]
부인암, 비뇨기암, 두경부암, 혈액암
외래진료 외래진료
특수클리닉 특수클리닉
진료일정
04
| 날짜 |
|---|
| 오전 |
| 오후 |
논문
논문
- Jang JY, Lee JH, Pyo H, Park W. Risk of rectal bleeding with endorectal balloon use after hypofractionated intensity-modulated radiotherapy for prostate cancer. BJU Int. Published online February 13, 2026. doi:10.1111/bju.70175.
- Lee TH, Lee H, Jang JY, et al. Refined risk stratification in residual triple-negative breast cancer after neoadjuvant therapy using residual cancer burden class and lymphovascular invasion. Breast Cancer Res Treat. 2026;215(3):76. Published 2026 Feb 5. doi:10.1007/s10549-026-07906-8.
- Yoo YJ, Jang JY, Kim SB, et al. Analysis of Recurrence Sites in Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiation with Elective Nodal Irradiation: Insights for Radiation Field Optimization. Ann Surg Oncol. 2025;32(10):7852-7859. doi:10.1245/s10434-025-17708-9.
- Jang JY, Seo JH, Choi JJ, et al. Insight into microbial extracellular vesicles as key communication materials and their clinical implications for lung cancer (Review). Int J Mol Med. 2025;56(2):119. doi:10.3892/ijmm.2025.5560.
- Jang JY, Pyo H, Yang K, Noh JM, Lee JH. Role of radiation alone vs. concurrent chemoradiotherapy in surgically ineligible patients with tracheobronchial squamous cell carcinoma. J Thorac Dis. 2025;17(3):1312-1322. doi:10.21037/jtd-24-1911.
- Jang JY. Contribution of Enhanced Locoregional Control to Improved Overall Survival with Consolidative Durvalumab After Concurrent Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer: Insights from Real-World Data. Cancer Research and Treatment. 2024 Jul;56(3):785-94.
- Shin YS, Jang JY, Yoo YJ, et al. Nomogram for predicting pathologic complete response following preoperative chemoradiotherapy in patients with esophageal squamous cell carcinoma. Gastroenterol Rep (Oxf). 2024;12:goae060. Published 2024 Jul 6. doi:10.1093/gastro/goae060.
- Lee JH, Jang JY, Noh JM, Yang K, Pyo H. Dose-Escalated Radiotherapy for Primary Tracheobronchial Adenoid Cystic Carcinoma. Cancers. 2024; 16(11):2127. https://doi.org/10.3390/cancers16112127.
- Lee E, Jang JY, Yang J. Uncommon Adverse Events of Immune Checkpoint Inhibitors in Small Cell Lung Cancer: A Systematic Review of Case Reports. Cancers. 2024; 16(10):1896. https://doi.org/10.3390/cancers16101896.
- Jang JY, Oh D, Noh JM, Sun JM, Kim HK, Shim YM. Prognostic impact of muscle mass loss in elderly patients with oesophageal cancer receiving neoadjuvant chemoradiation therapy. J Cachexia Sarcopenia Muscle. 2024;15(3):1167-1176. doi:10.1002/jcsm.13462.
- Jang JY, Park JH, Kim YJ, et al. Local control and toxicity outcomes following consolidative radiation therapy in patients with high-risk neuroblastoma: a 20-year experience at a single center. Turk J Pediatr. 2024;66(1):99-109. doi:10.24953/turkjped.2023.575.
- Jang JY, Kim K, Chen MF, Akimoto T, Wang MLC, Kim MJ, Kim K, Lee TH, Yoo GS, Park HC. A meta-analysis comparing efficacy and safety between proton beam therapy versus carbon ion radiotherapy. Cancer Med. 2024 Feb;13(3):e7023. doi: 10.1002/cam4.7023. PMID: 38396380; PMCID: PMC10891363.
- Jang JY, Song SY, Shin YS, et al. Contribution of Enhanced Locoregional Control to Improved Overall Survival with Consolidative Durvalumab After Concurrent Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer: Insights from Real-World Data. Cancer Res Treat. Published online January 16, 2024. doi:10.4143/crt.2023.1014.
- Jang JY, Kim SS, Song SY, Shin YS, Lee SW, Ji W, Choi CM, Choi EK. Clinical Outcome of Stereotactic Body Radiotherapy in Patients with Early-Stage Lung Cancer with Ground-Glass Opacity Predominant Lesions: A Single Institution Experience. Cancer Res Treat. 2023 Oct;55(4):1181-1189. doi: 10.4143/crt.2022.1656. Epub 2023 Mar 21. PMID: 36960626.
- Jang JY, Jung JH, Lee DB, Shim JH, Kim KM, Lim YS, Lee HC, Park JH, Yoon SM. Stereotactic body radiation therapy for elderly patients with small hepatocellular carcinoma: a retrospective observational study. J Liver Cancer . 2022; 22(2): 136-145. DOI: https://doi.org/10.17998/jlc.2022.08.18.
- Yu J, Kim JH, Kim SB, Park SR, Kim YH, Kim HR, Lee HJ, Song HJ, Song KJ, Jang JY, Jo YY, Yoo YJ. Role of Esophagectomy after Chemoradiation Therapy in Patients with Locally Advanced Squamous Cell Carcinoma: A Comparative Analysis Stratified by Clinical Response to Chemoradiation Therapy. Cancer Res Treat. 2022 Oct;54(4):1148-1156. doi: 10.4143/crt.2021.885. Epub 2021 Dec 20. PMID: 34942686; PMCID: PMC9582466.
- Jang JY, Kim SS, Song SY, Kim YJ, Kim SW, Choi EK. Radiation pneumonitis in patients with non-small-cell lung cancer receiving chemoradiotherapy and an immune checkpoint inhibitor: a retrospective study. Radiat Oncol. 2021 Dec 4;16(1):231. doi: 10.1186/s13014-021-01930-2. PMID: 34863244; PMCID: PMC8642976.
- Jo YY, Yu J, Song KJ, Jang JY, Yoo YJ, Kim SB, Park SR, Kim YH, Kim HR, Kim JH. Definitive chemoradiotherapy versus esophagectomy in patients with clinical T1bN0M0 esophageal squamous cell carcinoma: A retrospective study. Radiother Oncol. 2021 Sep;162:112-118. doi: 10.1016/j.radonc.2021.07.006. Epub 2021 Jul 13. PMID: 34265356.
- Jang JY, Yu J, Song KJ, Jo YY, Yoo YJ, Kim SB, Park SR, Kim YH, Kim HR, Kim JH. Prognostic significance of lymph node ratio after neoadjuvant chemoradiation therapy for esophageal squamous cell carcinoma. Radiat Oncol J. 2020 Dec;38(4):244-252. doi: 10.3857/roj.2020.00850. Epub 2020 Nov 25. PMID: 33233030; PMCID: PMC7785840.
- Kim H, Jung J, Kim J, Cho B, Kwak J, Jang JY, Lee SW, Lee JG, Yoon SM. Abdominal multi-organ auto-segmentation using 3D-patch-based deep convolutional neural network. Sci Rep. 2020 Apr 10;10(1):6204. doi: 10.1038/s41598-020-63285-0. PMID: 32277135; PMCID: PMC7148331.